Knockdown of BHLHE40 inhibits the proliferation, migration, invasion and PI3K/AKT signaling activity of osteosarcoma cells.
- Author:
Yang YANG
1
,
2
;
Fan YE
3
;
Litao SUN
4
Author Information
1. Department of Blood Transfusion, First Affiliated Hospital of Nanyang Medical College, Nanyang 473003, China. *Corresponding author, E-mail: yangyangssee55@
2. com.
3. First Ward of Department of Orthopedics, First Affiliated Hospital of Nanyang Medical College, Nanyang 473003, China.
4. Department of Blood Transfusion, First Affiliated Hospital of Nanyang Medical College, Nanyang 473003, China.
- Publication Type:Journal Article
- MeSH:
Osteosarcoma/metabolism*;
Humans;
Proto-Oncogene Proteins c-akt/genetics*;
Cell Proliferation/genetics*;
Cell Movement/genetics*;
Signal Transduction/genetics*;
Phosphatidylinositol 3-Kinases/genetics*;
Cell Line, Tumor;
Animals;
Neoplasm Invasiveness;
Basic Helix-Loop-Helix Transcription Factors/metabolism*;
Bone Neoplasms/metabolism*;
Mice;
Gene Knockdown Techniques;
Male;
Female;
Mice, Nude
- From:
Chinese Journal of Cellular and Molecular Immunology
2025;41(1):38-44
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of basic helix-loop-helix family member E40 (BHLHE40) on the invasion and migration of osteosarcoma (OS) cells, and to explore the role of the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway in the biological behavior of OS mediated by BHLHE40, providing a scientific basis for targeted therapy of OS. Methods On the basis of clinical OS samples and OS cell lines, the expression differences of BHLHE40 between OS and adjacent tissues, as well as those between OS cells and normal osteoblast cell lines, were analyzed. BHLHE40 knockdown OS cells were obtained through shRNA transfection. The effects of BHLHE40 on OS cell proliferation, migration, and invasion were examined using CCK-8, EdU staining, wound healing, and Transwell assays. The involvement of the PI3K/AKT signaling pathway was assessed by Western blotting. Further validation was conducted in vivo experiments. Results The expression of BHLHE40 was significantly higher in OS tissues compared to adjacent tissues. In OS cell lines, BHLHE40 protein expression levels were increased compared to normal osteoblasts, and the cell line with the highest BHLHE40 expression was selected for subsequent knockdown experiments. Compared with the knockdown control group, the BHLHE40 knockdown group exhibited reduced cell viability, EdU-positive cell count, colony number, cell migration, and invasion abilities, along with downregulation of phosphorylated PI3K(p-PI3K)/PI3K and p-AKT/AKT protein expression. The aforementioned functions of BHLHE40 were also reproduced in in vivo experiments. Conclusion BHLHE40 is highly expressed in OS tissues, and its knockdown can significantly inhibit OS cell proliferation, migration, and invasion, while reducing PI3K/AKT signaling pathway activity. This suggests that BHLHE40 could serve as a novel therapeutic target for OS.
